Steven Cohen’s AbbVie ABBV Stock Holding History

Steven Cohen’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Sell	9,900 -12,600	-56%	-$2.71M	﹤0.01%	2245
2026 Q1	$4.89M	Sell	22,500 -6,800	-23%	-$1.51M	0.01%	1717
2025 Q4	$6.69M	Buy	+29,300	New	+$6.67M	0.01%	1612
2025 Q2	–	Sell	-70,000	Closed	-$14.7M	–	2127
2025 Q1	$14.7M	Buy	+70,000	New	+$13.6M	0.03%	543
2021 Q2	–	Sell	-100,000	Closed	-$10.8M	–	943
2021 Q1	$10.8M	Buy	+100,000	New	+$10.7M	0.05%	408
2018 Q4	–	Sell	-187,900	Closed	-$17.8M	–	925
2018 Q3	$17.8M	Buy	+187,900	New	+$17.8M	0.07%	329

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steven Cohen's ABBV Position: Q2 2026 in Review

Steven Cohen opened a new position in AbbVie (ABBV) in Q2 2026: 366,836 shares worth $92.3M. The stake represents 0.1% of the portfolio and ranks #227 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ABBV as recently as Q3 2025.

Steven Cohen first reported a position in ABBV in Q3 2014 and has held it in 20 quarters since. The position peaked at $164M in Q1 2023. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Steven Cohen held 366,836 shares of AbbVie worth $92.3M as of Q2 2026.
AbbVie was a new Steven Cohen position in Q2 2026.
AbbVie made up 0.1% of Steven Cohen's portfolio in Q2 2026, its #227 holding.
Steven Cohen first reported a position in AbbVie in Q3 2014 and has held it in 20 quarters since.
Steven Cohen's AbbVie position peaked at $164M in Q1 2023.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.